Related Tags >> Generics Patent Teva Pharmaceutical FDA approval

Barr Pharmaceuticals News

Most Popular Barr Pharmaceuticals Story

Bayer loses Yasmin patent fight

March 4, 2008 — 6:59am ET

Bayer had the Yasmin rug pulled out from under it yesterday. A U.S. court voided the contraceptive's key patent, leading the German conglomerate to revise its 2008 profit expectations Read more...

Barr Pharmaceuticals Press Releases

Latest Headlines

Supremes refuse to hear pay-for-delay challenge
March 8, 2011
Judge orders broader access to Plan B
March 24, 2009
Teva and Barr settle patent dispute
November 19, 2008
Generics makers anticipate Obama boon
November 6, 2008
Barr, Teva merger poised for tax-free status
August 20, 2008
Amgen sues Barr over generic Sensipar
July 30, 2008
It's Teva plus Barr in a $7.46B buyout
July 18, 2008
Rumor mill: Teva mulling $7.5B deal for Barr
July 17, 2008
Barr closer to launching RLS generic
June 27, 2008
Barr, Bayer clinch generic Yasmin deal
June 24, 2008
Companies sue over generic Prevacid SoluTab
June 11, 2008
ALSO NOTED: Apotex assails Canadian goodwill drug program; Amgen CEO: "I felt real economic pain";
May 9, 2008
ALSO NOTED: High-dose Celebrex triples heart risk; Actos slows plaque buildup in arteries;
April 1, 2008
ALSO NOTED: Barr gets FDA's blessing for generic Taxol; Biovail founder wants to reform company's board;
March 13, 2008
ALSO NOTED: Government could force doc disclosures; Barr sues Watson over Seasonique patent;
March 6, 2008
Bayer loses Yasmin patent fight
March 4, 2008
ALSO NOTED: Pro-compulsory license official reassigned in Thailand; Galderma to nab CollaGenex for $420M
February 27, 2008
FTC sues Cephalon for blocking generics
February 14, 2008
ALSO NOTED: Teva, Barr get OK to sell Fosamax copies; Ranbaxy wins FDA nod for copycat Nexium;
February 7, 2008
ALSO NOTED: J&J expects global sales to goose profits; Pfizer's lower earnings still beat analysts;
January 23, 2008

Paid Research Reports

More Research Reports >>